Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328432 · ClinicalTrials.gov registry record · Phase 1
A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
A Phase 1 study, sponsored by University of Kansas.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT00328432 is a Phase 1 study that has completed, run by University of Kansas. The registered enrollment target is 100 participants.
The verdict
NCT00328432, a Phase 1 study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
To assess the effects of short term administration of celecoxib 400 mg bid between biopsy and reexcision.
Interventions
- DRUG celecoxib 400 mg bid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00328432
The ClinicalTrials.gov registry entry for NCT00328432 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which celecoxib 400 mg bid is the first listed.
NCT00328432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00328432 about?
NCT00328432 is a clinical study titled "A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy". To assess the effects of short term administration of celecoxib 400 mg bid between biopsy and reexcision.
What is the current status of trial NCT00328432?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2003-06. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00328432?
The interventions under investigation include: celecoxib 400 mg bid (DRUG).
Who is sponsoring clinical trial NCT00328432?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.